Detailed answers about PRIME PHARMACY LIMITED, including incorporation, status, business activity, and accounts information.
When was PRIME PHARMACY LIMITED founded?
PRIME PHARMACY LIMITED was officially incorporated on 1 July 2022 and is registered under company number 14208016. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PRIME PHARMACY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PRIME PHARMACY LIMITED?
PRIME PHARMACY LIMITED's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PRIME PHARMACY LIMITED do?
PRIME PHARMACY LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is PRIME PHARMACY LIMITED's registered address?
The registered office address of PRIME PHARMACY LIMITED is SUITE 18 SPACE HOUSE, ABBEY ROAD, LONDON, ENGLAND, NW10 7SU. This is the official address filed with Companies House for legal and statutory correspondence.
Is PRIME PHARMACY LIMITED financially stable?
The most recent accounts for PRIME PHARMACY LIMITED were made up to 31 July 2023, filed as DORMANT. Next accounts are due by 30 April 2025.
Does PRIME PHARMACY LIMITED have any charges or mortgages?
PRIME PHARMACY LIMITED has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.